Clinical Trials · NCT07081178
A Non-interventional Study Investigating Semaglutide in Combination With Lifestyle-based Modifications for the Management of Obesity in Real-World Clinical Practice in Germany (WeGo Real Germany).
- Phase
- N/A
- Recruitment status
- Terminated
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 100
- Start date
- Aug 2025
- Locations
- 1 site, Germany
- Primary endpoint
- Change in relative body weight